Get the Stockscreener App
2.59
3.72%
-0.10
Nrx Pharmaceuticals Inc stock is traded at $2.59, with a volume of 124.63K.
It is down -3.72% in the last 24 hours and down -17.25% over the past month.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
See More
Previous Close:
$2.69
Open:
$2.66
24h Volume:
124.63K
Relative Volume:
0.48
Market Cap:
$50.51M
Revenue:
-
Net Income/Loss:
$-30.15M
P/E Ratio:
-0.6475
EPS:
-4
Net Cash Flow:
$-21.66M
1W Performance:
-13.67%
1M Performance:
-17.25%
6M Performance:
-14.24%
1Y Performance:
+20.47%
1-Day Range:
$2.56
$2.6899
1-Week Range:
$2.56
$3.02
52-Week Range:
$1.10
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Name
Nrx Pharmaceuticals Inc
Sector
Industry
Phone
484-254-6134
Address
1201 ORANGE STREET, WILMINGTON
Compare NRXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
2.59 | 52.46M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-02-25 | Initiated | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Stock (NRXP) Latest News
Is it the right time to buy NRx Pharmaceuticals Inc. stockWealth Building Picks That Work - jammulinksnews.com
What is NRx Pharmaceuticals Inc. company’s growth strategyRetirement Planning Watchlist For Fast Growth - jammulinksnews.com
New to The Street Show #682 Premieres on Bloomberg Tonight Featuring Industry Leaders: DataVault, PetVivo, Health In Tech, FLOKI, and NRx Pharma Backed by National TV Commercials and Outdoor Campaigns Sponsored by MUSQ, ArriveAI, and Sustai - ACCESS Newswire
NRx Pharmaceuticals Inc. Equity Warrant Forms Double Bottom Pattern — Eyes on BreakoutInvestment Playbook for Growing Markets Shared - metal.it
How does NRx Pharmaceuticals Inc. generate profit in a changing economyFree Stock Recommendation For Fast Growth - jammulinksnews.com
What institutional investors are buying NRx Pharmaceuticals Inc. stockReal Time Watchlist With Proven Results - jammulinksnews.com
NRx Pharmaceuticals to Join BTIG Virtual Biotech Conference - AInvest
What are analysts’ price targets for NRx Pharmaceuticals Inc. in the next 12 monthsBreakout Stocks Watchlist That Work - jammulinksnews.com
NRx Pharmaceuticals (NASDAQ: NRXP) CEO to Join Fireside Chat at BTIG Virtual Biotechnology Conference - MSN
Top chart patterns to watch in NRx Pharmaceuticals Inc. Equity WarrantSafe Entry Stock Watch Suggestions for Cautious Traders - metal.it
RSI Crosses Above 30 for NRx Pharmaceuticals Inc. — Reversal in SightBreakout Entry Signal Confirmation Tool Used - metal.it
Published on: 2025-07-29 21:24:51 - metal.it
NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join Fireside Chat at BTIG Virtual Biotech Conference July 2930, 2025 - Nasdaq
NRx Pharmaceuticals Teams with Yale Expert to Reveal Latest CNS Treatment Innovations at BTIG Conference - Stock Titan
Wyckoff Accumulation Phase Possible in NRx Pharmaceuticals Inc.High Win Rate Trading Opportunities Detected - metal.it
What makes NRx Pharmaceuticals Inc. stock price move sharplyStable Entry High Return Opportunities in Focus - metal.it
How many analysts rate NRx Pharmaceuticals Inc. Equity Warrant as a “Buy”Free Stock Outlook That Work - jammulinksnews.com
How many analysts rate NRx Pharmaceuticals Inc. as a “Buy”Achieve breakthrough performance with smart picks - jammulinksnews.com
What are NRx Pharmaceuticals Inc. company’s key revenue driversBuild wealth faster with disciplined trading - jammulinksnews.com
What are the latest earnings results for NRx Pharmaceuticals Inc.Amplify your gains with low-risk picks - jammulinksnews.com
Does NRx Pharmaceuticals Inc. stock perform well during market downturnsFree Predictions - jammulinksnews.com
Should I hold or sell NRx Pharmaceuticals Inc. stock in 2025Capitalize on market trends with expert guidance - jammulinksnews.com
What makes NRx Pharmaceuticals Inc. Equity Warrant stock price move sharplyCapitalize on market momentum for maximum gains - jammulinksnews.com
How volatile is NRx Pharmaceuticals Inc. stock compared to the marketCapitalize on market trends with confidence - jammulinksnews.com
How does NRx Pharmaceuticals Inc. Equity Warrant compare to its industry peersFree Consultation - jammulinksnews.com
How strong is NRx Pharmaceuticals Inc. Equity Warrant company’s balance sheetFree Daily Trading Room Entry - jammulinksnews.com
What are NRx Pharmaceuticals Inc. Equity Warrant company’s key revenue driversHarness the power of proven investment plans - jammulinksnews.com
Why is NRx Pharmaceuticals Inc. stock attracting strong analyst attentionGet daily expert analysis on top stocks - jammulinksnews.com
How does NRx Pharmaceuticals Inc. compare to its industry peersFastest return on investment - jammulinksnews.com
How does NRx Pharmaceuticals Inc. Equity Warrant generate profit in a changing economyRapid return acceleration - jammulinksnews.com
Is NRx Pharmaceuticals Inc. stock overvalued or undervaluedInvest smarter with cutting-edge analytics - jammulinksnews.com
NRx Pharmaceuticals Inc. Equity Warrant Company’s Quarterly Earnings Growth: What the Numbers SayFree Stock Market Swing Trading Strategies - metal.it
Should I hold or sell NRx Pharmaceuticals Inc. Equity Warrant stock in 2025Capitalize on fast-moving market trends - jammulinksnews.com
Nrx Pharmaceuticals Inc Stock (NRXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):